data_1pxq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pxq _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -72.86 -8.95 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.95 -48.04 43.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.674 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.7 m -76.59 49.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.19 -22.58 26.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.766 0.317 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 t -65.81 -9.62 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.76 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.78 46.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.993 0.425 . . . . 0.0 110.76 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.7 m -57.8 -20.8 38.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -44.57 -71.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.242 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.41 153.52 7.55 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.872 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.03 115.54 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 111.053 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.24 89.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HA ' ' N ' ' A' ' 23' ' ' GLU . 1.7 m -66.9 -37.22 83.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.8 mt 76.38 1.43 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.994 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.506 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 10.4 p -66.67 -2.01 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.06 21.17 10.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.107 0.479 . . . . 0.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -157.86 -92.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.505 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.2 Cg_endo -54.73 -28.66 58.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.574 2.183 . . . . 0.0 112.024 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.603 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 39.9 mm 85.98 32.12 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 48.7 Cg_endo -68.77 -19.89 40.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.141 1.894 . . . . 0.0 112.61 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.2 t0 77.52 119.02 0.05 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 21' ' ' ASP . 5.4 p90 15.52 56.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' N ' ' HA ' ' A' ' 13' ' ' CYS . 52.4 mm-40 -89.21 68.98 8.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.989 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mt -88.25 -51.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.85 28.58 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.23 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.57 78.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.691 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.586 0.232 . . . . 0.0 111.62 179.771 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.23 0 N-CA-C 113.372 0.109 . . . . 0.0 113.372 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.902 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.4 mt -64.72 -17.7 64.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.707 0.289 . . . . 0.0 111.186 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -107.6 -28.77 9.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.79 0.328 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.442 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.873 0.368 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -82.7 -81.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.25 34.12 4.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.573 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.7 m -74.58 -5.75 44.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.543 0.211 . . . . 0.0 111.567 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.64 -2.51 36.3 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -4.01 42.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 111.459 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.02 65.92 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.93 0.395 . . . . 0.0 110.262 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -50.26 -27.03 5.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.82 102.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.72 163.24 50.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.788 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.98 111.58 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.96 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.83 88.15 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -66.44 -23.04 66.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.336 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt 67.07 1.83 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.685 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 10.2 p -66.22 -6.88 4.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.839 0.352 . . . . 0.0 110.98 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.86 29.28 3.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.313 0.578 . . . . 0.0 110.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.57 -93.98 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.501 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.2 Cg_endo -53.99 -31.63 64.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.629 2.22 . . . . 0.0 111.975 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.577 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 27.3 mm 86.01 35.02 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 74.3 Cg_endo -73.24 -22.49 18.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.169 1.912 . . . . 0.0 112.15 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t0 78.61 109.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.036 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 32.2 55.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.467 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -88.12 51.31 2.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 111.241 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.83 -66.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.1 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.27 44.11 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.67 91.52 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.567 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.551 0.215 . . . . 0.0 111.327 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.593 -0.203 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.812 0.339 . . . . 0.0 111.231 179.884 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 120.434 -0.092 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.421 ' CD1' ' C ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -80.79 1.0 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -112.99 34.05 4.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.871 0.367 . . . . 0.0 110.807 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.512 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.833 0.349 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -82.49 86.66 6.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.11 72.41 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.0 m -156.97 26.29 0.32 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.709 0.29 . . . . 0.0 110.7 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.4 13.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 p -78.23 41.93 0.39 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 6' ' ' THR . 23.6 p 174.83 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.883 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 t -50.63 -25.8 4.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.868 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mm -52.25 104.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.807 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.94 174.41 0.04 OUTLIER Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.936 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.57 113.82 12.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 111.222 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.01 80.08 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -73.71 -24.97 59.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.402 ' O ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER 67.6 2.42 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.297 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.531 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.9 p -66.25 -3.93 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 110.981 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.12 25.46 6.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.144 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.48 -102.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.424 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 9.6 Cg_endo -53.4 -25.62 32.25 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.47 2.114 . . . . 0.0 112.102 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.562 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 2.7 mp 86.05 37.71 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 53.8 Cg_endo -69.09 -22.69 34.79 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.28 1.987 . . . . 0.0 112.222 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 t0 76.13 109.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.995 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.5 p90 31.24 58.0 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 0.2 OUTLIER -93.64 41.08 1.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.945 0.402 . . . . 0.0 111.665 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -58.76 -33.23 48.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.999 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.85 25.16 13.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.43 63.47 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.366 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 110.844 179.794 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.709 -0.156 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -30.25 71.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 110.982 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.01 75.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.432 HD21 ' N ' ' A' ' 1' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 121.106 0.479 . . . . 0.0 111.363 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.64 54.0 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.84 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.68 -51.07 2.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 m 42.16 31.82 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.9 -4.52 59.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.822 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.4 p -72.95 -5.08 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.252 . . . . 0.0 111.455 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -154.89 65.83 0.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.043 0.449 . . . . 0.0 110.107 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -50.18 -25.86 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 1.4 mp -54.97 -66.58 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.346 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 50.21 -140.9 17.4 Favored Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.358 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 106.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.912 0.387 . . . . 0.0 111.567 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.13 28.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.489 ' HB2' HG13 ' A' ' 24' ' ' ILE . 11.2 t -79.62 -29.58 41.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.83 0.348 . . . . 0.0 110.637 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' CB ' ' CG ' ' A' ' 20' ' ' PRO . 8.0 mt 69.93 3.1 4.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.613 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.468 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 7.4 p -66.34 -7.24 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.965 0.412 . . . . 0.0 110.396 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.17 31.66 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.56 -94.9 0.1 OUTLIER Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.088 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 38.4 Cg_endo -67.29 -38.06 16.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.68 2.254 . . . . 0.0 112.462 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 29.7 mm 86.21 59.82 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.439 ' CG ' ' CB ' ' A' ' 14' ' ' LEU . 64.2 Cg_endo -95.12 28.22 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.112 2.542 . . . . 0.0 111.715 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 23' ' ' GLU . 6.8 t70 63.27 117.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.847 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.449 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 9.3 p90 -24.78 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.659 0.599 . . . . 0.0 112.12 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -88.89 55.13 3.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.777 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 13' ' ' CYS . 12.0 mt -88.89 -70.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 67.67 41.15 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.413 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.62 76.8 0.02 OUTLIER Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.357 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.246 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.786 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.645 0.26 . . . . 0.0 111.169 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 112.906 -0.077 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.91 4.25 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -131.85 34.97 3.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.437 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.696 179.662 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.85 0.357 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -83.15 41.51 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.288 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.07 -46.3 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.78 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m 45.75 26.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.192 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.12 -6.53 58.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.692 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 p -77.46 0.13 23.85 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -155.27 49.78 0.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.068 0.461 . . . . 0.0 110.801 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t -51.01 -22.5 2.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.347 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -44.76 -30.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.418 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.47 176.02 23.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.584 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.96 124.51 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 111.248 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.73 57.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' SG ' ' HB ' ' A' ' 15' ' ' VAL . 7.0 t -71.23 -30.1 65.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 6.2 mp 70.05 2.7 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.705 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.476 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 7.3 p -66.28 -6.32 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.042 0.449 . . . . 0.0 110.282 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 30.32 2.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -161.31 -96.11 0.11 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.908 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 63.4 Cg_endo -73.35 -28.51 12.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.583 2.189 . . . . 0.0 112.357 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.487 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 28.8 mm 86.03 58.83 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.44 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 21' ' ' ASP . 72.7 Cg_endo -94.19 38.82 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.914 2.409 . . . . 0.0 112.189 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 48.32 109.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.373 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -14.67 83.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.423 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.457 ' N ' ' HA ' ' A' ' 13' ' ' CYS . 10.2 pt-20 -86.49 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.964 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 24' ' ' ILE . 25.6 mm -75.83 -62.59 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 61.81 24.61 14.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.46 74.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.816 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.568 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.265 0 CA-C-O 120.472 -0.071 . . . . 0.0 113.185 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.298 -179.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.331 0 CA-C-O 120.356 -0.135 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.2 mt -93.59 13.39 22.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.818 0.309 . . . . 0.0 111.769 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.09 -76.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.309 . . . . 0.0 111.141 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.546 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.426 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.803 0.335 . . . . 0.0 110.97 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -62.87 -17.8 62.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.3 -26.59 6.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.759 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.2 m -75.59 -1.25 23.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.95 -51.8 17.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 111.165 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -78.21 49.7 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.62 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 29' ' ' GLY . 23.6 p -178.26 44.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.597 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -50.9 -25.91 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 4.1 mm -58.37 -74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 79.99 -142.69 24.57 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.867 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.63 107.33 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 111.447 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.97 79.28 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HA ' ' N ' ' A' ' 23' ' ' GLU . 4.7 m -66.68 -31.1 71.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.187 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 mt 69.78 5.12 5.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.648 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 11.0 p -66.25 -2.25 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -98.08 22.59 9.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.13 -104.7 0.36 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.9 Cg_endo -55.32 -21.87 30.97 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.172 1.914 . . . . 0.0 111.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 2.9 mp 86.21 43.0 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.648 ' HD2' ' HA ' ' A' ' 15' ' ' VAL . 18.3 Cg_endo -56.36 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.877 1.718 . . . . 0.0 111.221 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 20' ' ' PRO . 1.4 p30 154.52 82.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.859 0.464 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 47.53 44.62 17.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.888 0.375 . . . . 0.0 110.334 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.465 ' N ' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -65.08 115.1 5.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 111.805 -178.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.0 mt -89.05 -77.7 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.815 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 43.0 30.21 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.798 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.11 46.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.725 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.236 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.663 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 113.56 0.184 . . . . 0.0 113.56 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.774 0.287 . . . . 0.0 111.078 -179.858 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.375 0 N-CA-C 113.405 0.122 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 10.98 19.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.99 82.88 1.98 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 110.379 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.489 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.451 ' HB3' ' N ' ' A' ' 35' ' ' GLY . 1.1 p30 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.898 0.38 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 60.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.21 8.21 42.56 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.675 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 37.73 -161.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.689 0.396 . . . . 0.0 111.872 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.84 -176.09 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.221 0.534 . . . . 0.0 112.119 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.0 p -78.58 58.82 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.261 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -153.52 34.65 0.45 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.286 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.445 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 14.3 m -50.27 -27.45 6.09 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.169 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.4 mm -61.21 -20.58 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.988 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' GLY . . . -47.31 -68.68 1.09 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.312 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.26 64.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 111.323 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.59 75.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 1.7 m -70.9 -36.01 72.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 6.9 mp 73.82 3.59 4.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.108 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.525 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 9.9 p -66.02 -2.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.269 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.56 23.3 7.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.205 0.526 . . . . 0.0 110.254 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.55 -100.18 0.17 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.604 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.9 Cg_endo -53.94 -22.26 23.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.574 2.182 . . . . 0.0 112.548 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.607 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 3.0 mp 85.77 34.45 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 37.9 Cg_endo -65.35 -25.98 56.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.592 2.195 . . . . 0.0 112.737 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.1 t0 77.51 113.55 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.036 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.8 p90 15.97 57.64 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' CG ' ' HB2' ' A' ' 20' ' ' PRO . 10.5 mm-40 -74.44 69.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.365 . . . . 0.0 110.797 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mt -66.4 -66.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.13 32.01 20.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.737 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.404 ' O ' ' CA ' ' A' ' 10' ' ' GLY . . . 133.64 95.12 0.54 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.404 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 120.454 -0.081 . . . . 0.0 113.151 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.8 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.858 0.361 . . . . 0.0 110.905 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . . . . . . 0 N--CA 1.449 -0.454 0 N-CA-C 112.953 -0.059 . . . . 0.0 112.953 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 pp -93.8 1.42 56.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -107.33 -77.34 0.6 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.678 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' N ' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 C--N 1.331 0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.764 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.814 0.34 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.72 57.45 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.56 -60.96 3.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.648 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.5 m 45.6 29.32 0.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.331 . . . . 0.0 111.447 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.7 -17.5 35.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.3 p -61.49 -16.41 47.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -154.48 43.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.651 0.262 . . . . 0.0 111.044 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -30.79 11.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.159 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 6.3 mm -75.55 91.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.13 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.82 -38.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.892 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.19 44.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 111.241 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.21 95.11 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.325 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.448 ' HA ' ' HG3' ' A' ' 23' ' ' GLU . 1.7 m -66.18 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.365 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 41.9 mt 76.47 6.04 3.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.553 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 7.2 p -66.31 -5.67 3.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.815 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -98.14 27.21 4.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.249 0.547 . . . . 0.0 109.998 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -165.43 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.178 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.5 Cg_endo -52.69 -32.11 53.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.6 2.2 . . . . 0.0 111.861 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 2.7 mt 86.17 33.68 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 67.7 Cg_endo -72.51 -20.77 23.27 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.043 1.829 . . . . 0.0 112.316 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.3 t0 76.39 105.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.878 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 21' ' ' ASP . 1.3 p90 29.3 53.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.36 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HG3' ' HA ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -56.84 112.67 1.38 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 111.28 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.26 -76.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 53.07 32.88 13.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.572 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.22 95.35 1.4 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.699 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.163 0 CA-C-O 120.526 -0.041 . . . . 0.0 113.156 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.9 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 0.0 111.314 -179.803 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.24 0 CA-C-O 120.42 -0.1 . . . . 0.0 112.95 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.0 mt -93.68 25.52 3.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.359 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -130.17 -76.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.57 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -72.86 -8.95 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.95 -48.04 43.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.674 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.7 m -76.59 49.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.19 -22.58 26.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.766 0.317 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 t -65.81 -9.62 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.76 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.78 46.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.993 0.425 . . . . 0.0 110.76 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.7 m -57.8 -20.8 38.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -44.57 -71.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.242 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.41 153.52 7.55 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.872 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.03 115.54 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 111.053 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.24 89.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HA ' ' N ' ' A' ' 23' ' ' GLU . 1.7 m -66.9 -37.22 83.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.8 mt 76.38 1.43 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.994 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.506 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 10.4 p -66.67 -2.01 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.06 21.17 10.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.107 0.479 . . . . 0.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -157.86 -92.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.505 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.2 Cg_endo -54.73 -28.66 58.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.574 2.183 . . . . 0.0 112.024 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.603 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 39.9 mm 85.98 32.12 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 48.7 Cg_endo -68.77 -19.89 40.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.141 1.894 . . . . 0.0 112.61 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.2 t0 77.52 119.02 0.05 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 21' ' ' ASP . 5.4 p90 15.52 56.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' N ' ' HA ' ' A' ' 13' ' ' CYS . 52.4 mm-40 -89.21 68.98 8.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.989 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mt -88.25 -51.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.85 28.58 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.23 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.57 78.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.691 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.67 -6.63 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.586 0.232 . . . . 0.0 111.62 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' 2TL . . . . . 0.433 ' CG2' ' O ' ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -42.6 -30.28 0.87 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.372 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.2 mt -60.34 -33.45 72.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.902 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.96 -26.61 15.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.381 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.4 mt -64.72 -17.7 64.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.707 0.289 . . . . 0.0 111.186 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -107.6 -28.77 9.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.79 0.328 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.442 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.873 0.368 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -82.7 -81.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.25 34.12 4.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.573 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.7 m -74.58 -5.75 44.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.543 0.211 . . . . 0.0 111.567 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.64 -2.51 36.3 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -4.01 42.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 111.459 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.02 65.92 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.93 0.395 . . . . 0.0 110.262 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -50.26 -27.03 5.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.82 102.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.72 163.24 50.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.788 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.98 111.58 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.96 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.83 88.15 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -66.44 -23.04 66.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.336 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt 67.07 1.83 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.685 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 10.2 p -66.22 -6.88 4.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.839 0.352 . . . . 0.0 110.98 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.86 29.28 3.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.313 0.578 . . . . 0.0 110.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.57 -93.98 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.501 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.2 Cg_endo -53.99 -31.63 64.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.629 2.22 . . . . 0.0 111.975 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.577 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 27.3 mm 86.01 35.02 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 74.3 Cg_endo -73.24 -22.49 18.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.169 1.912 . . . . 0.0 112.15 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t0 78.61 109.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.036 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 32.2 55.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.467 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -88.12 51.31 2.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 111.241 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.83 -66.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.1 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.27 44.11 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.67 91.52 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.567 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 28' ' ' 2TL . . . -70.03 -30.12 67.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.551 0.215 . . . . 0.0 111.327 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' 2TL . . . . . 0.425 ' OG1' ' O ' ' A' ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.05 -52.28 3.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.593 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.6 mt -47.46 -27.98 1.97 Allowed 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.812 0.339 . . . . 0.0 111.231 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.72 96.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.285 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.421 ' CD1' ' C ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -80.79 1.0 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -112.99 34.05 4.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.871 0.367 . . . . 0.0 110.807 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.512 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.833 0.349 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -82.49 86.66 6.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.11 72.41 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.446 ' HA ' HG21 ' A' ' 28' ' ' 2TL . 58.0 m -156.97 26.29 0.32 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.709 0.29 . . . . 0.0 110.7 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.4 13.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 p -78.23 41.93 0.39 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.445 ' O ' ' C ' ' A' ' 28' ' ' 2TL . 23.6 p 174.83 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.883 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 t -50.63 -25.8 4.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.868 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mm -52.25 104.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.807 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.94 174.41 0.04 OUTLIER Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.936 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.57 113.82 12.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 111.222 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.01 80.08 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -73.71 -24.97 59.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.402 ' O ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER 67.6 2.42 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.297 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.531 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.9 p -66.25 -3.93 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 110.981 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.12 25.46 6.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.144 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.48 -102.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.424 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 9.6 Cg_endo -53.4 -25.62 32.25 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.47 2.114 . . . . 0.0 112.102 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.562 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 2.7 mp 86.05 37.71 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 53.8 Cg_endo -69.09 -22.69 34.79 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.28 1.987 . . . . 0.0 112.222 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 t0 76.13 109.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.995 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.5 p90 31.24 58.0 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 0.2 OUTLIER -93.64 41.08 1.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.945 0.402 . . . . 0.0 111.665 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -58.76 -33.23 48.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.999 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.85 25.16 13.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.43 63.47 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.366 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 28' ' ' 2TL . . . -72.66 65.6 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 110.844 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' 2TL . . . . . 0.539 ' CB ' ' O ' ' A' ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.88 -19.79 52.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.313 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt -72.46 -30.16 64.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.36 -55.94 7.28 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.709 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -30.25 71.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 110.982 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.01 75.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.432 HD21 ' N ' ' A' ' 1' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 121.106 0.479 . . . . 0.0 111.363 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.64 54.0 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.84 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.68 -51.07 2.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 m 42.16 31.82 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.9 -4.52 59.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.822 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.4 p -72.95 -5.08 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.252 . . . . 0.0 111.455 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -154.89 65.83 0.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.043 0.449 . . . . 0.0 110.107 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -50.18 -25.86 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 1.4 mp -54.97 -66.58 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.346 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 50.21 -140.9 17.4 Favored Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.358 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 106.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.912 0.387 . . . . 0.0 111.567 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.13 28.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.489 ' HB2' HG13 ' A' ' 24' ' ' ILE . 11.2 t -79.62 -29.58 41.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.83 0.348 . . . . 0.0 110.637 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' CB ' ' CG ' ' A' ' 20' ' ' PRO . 8.0 mt 69.93 3.1 4.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.613 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.468 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 7.4 p -66.34 -7.24 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.965 0.412 . . . . 0.0 110.396 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.17 31.66 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.56 -94.9 0.1 OUTLIER Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.088 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 38.4 Cg_endo -67.29 -38.06 16.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.68 2.254 . . . . 0.0 112.462 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 29.7 mm 86.21 59.82 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.439 ' CG ' ' CB ' ' A' ' 14' ' ' LEU . 64.2 Cg_endo -95.12 28.22 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.112 2.542 . . . . 0.0 111.715 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 23' ' ' GLU . 6.8 t70 63.27 117.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.847 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.449 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 9.3 p90 -24.78 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.659 0.599 . . . . 0.0 112.12 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -88.89 55.13 3.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.777 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 13' ' ' CYS . 12.0 mt -88.89 -70.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 67.67 41.15 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.413 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.62 76.8 0.02 OUTLIER Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.357 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 28' ' ' 2TL . . . -72.79 -3.6 26.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' 2TL . . . . . 0.429 ' O ' ' CG2' ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -57.63 -30.74 62.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.718 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.7 mt -57.14 -22.02 36.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.645 0.26 . . . . 0.0 111.169 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' DPN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 34' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.35 -40.29 98.76 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.906 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.91 4.25 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 31' ' ' DPN . 9.6 t-105 -131.85 34.97 3.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.437 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.696 179.662 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.85 0.357 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -83.15 41.51 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.288 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.07 -46.3 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.78 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m 45.75 26.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.192 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.12 -6.53 58.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.692 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 p -77.46 0.13 23.85 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -155.27 49.78 0.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.068 0.461 . . . . 0.0 110.801 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t -51.01 -22.5 2.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.347 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -44.76 -30.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.418 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.47 176.02 23.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.584 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.96 124.51 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 111.248 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.73 57.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' SG ' ' HB ' ' A' ' 15' ' ' VAL . 7.0 t -71.23 -30.1 65.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 6.2 mp 70.05 2.7 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.705 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.476 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 7.3 p -66.28 -6.32 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.042 0.449 . . . . 0.0 110.282 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 30.32 2.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -161.31 -96.11 0.11 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.908 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 63.4 Cg_endo -73.35 -28.51 12.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.583 2.189 . . . . 0.0 112.357 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.487 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 28.8 mm 86.03 58.83 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.44 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 21' ' ' ASP . 72.7 Cg_endo -94.19 38.82 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.914 2.409 . . . . 0.0 112.189 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 48.32 109.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.373 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -14.67 83.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.423 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' N ' ' HA ' ' A' ' 13' ' ' CYS . 10.2 pt-20 -86.49 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.964 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 24' ' ' ILE . 25.6 mm -75.83 -62.59 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 61.81 24.61 14.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.46 74.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.816 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 28' ' ' 2TL . . . -72.95 0.51 11.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' 2TL . . . . . 0.45 ' C ' ' O ' ' A' ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -46.43 -33.03 5.69 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.185 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.9 mt -61.23 -18.28 57.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.298 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.57 -11.13 68.17 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.081 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.2 mt -93.59 13.39 22.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.818 0.309 . . . . 0.0 111.769 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.09 -76.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.309 . . . . 0.0 111.141 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.546 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.426 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.803 0.335 . . . . 0.0 110.97 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -62.87 -17.8 62.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.3 -26.59 6.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.759 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.466 ' HA ' ' OG1' ' A' ' 28' ' ' 2TL . 33.2 m -75.59 -1.25 23.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.95 -51.8 17.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 111.165 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -78.21 49.7 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.62 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 29' ' ' GLY . 23.6 p -178.26 44.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.597 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -50.9 -25.91 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 4.1 mm -58.37 -74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . 79.99 -142.69 24.57 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.867 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.63 107.33 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 111.447 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.97 79.28 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HA ' ' N ' ' A' ' 23' ' ' GLU . 4.7 m -66.68 -31.1 71.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.187 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 mt 69.78 5.12 5.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.648 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 11.0 p -66.25 -2.25 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -98.08 22.59 9.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.13 -104.7 0.36 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.9 Cg_endo -55.32 -21.87 30.97 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.172 1.914 . . . . 0.0 111.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 2.9 mp 86.21 43.0 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.648 ' HD2' ' HA ' ' A' ' 15' ' ' VAL . 18.3 Cg_endo -56.36 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.877 1.718 . . . . 0.0 111.221 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 20' ' ' PRO . 1.4 p30 154.52 82.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.859 0.464 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 47.53 44.62 17.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.888 0.375 . . . . 0.0 110.334 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.465 ' N ' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -65.08 115.1 5.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 111.805 -178.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.0 mt -89.05 -77.7 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.815 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 43.0 30.21 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.798 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.11 46.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.725 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.13 4.72 4.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' 2TL . . . . . 0.466 ' OG1' ' HA ' ' A' ' 4' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -43.05 -29.33 0.88 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.56 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -64.61 -31.57 72.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.774 0.287 . . . . 0.0 111.078 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.56 -39.79 16.03 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.405 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 10.98 19.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.99 82.88 1.98 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 110.379 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.489 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.451 ' HB3' ' N ' ' A' ' 35' ' ' GLY . 1.1 p30 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.898 0.38 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 60.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.21 8.21 42.56 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.675 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 37.73 -161.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.689 0.396 . . . . 0.0 111.872 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.444 ' HB2' ' HB ' ' A' ' 28' ' ' 2TL . . . -69.84 -176.09 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.221 0.534 . . . . 0.0 112.119 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.0 p -78.58 58.82 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.261 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -153.52 34.65 0.45 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.286 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.445 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 14.3 m -50.27 -27.45 6.09 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.169 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.4 mm -61.21 -20.58 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.988 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' GLY . . . -47.31 -68.68 1.09 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.312 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.26 64.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 111.323 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.59 75.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 1.7 m -70.9 -36.01 72.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 6.9 mp 73.82 3.59 4.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.108 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.525 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 9.9 p -66.02 -2.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.269 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.56 23.3 7.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.205 0.526 . . . . 0.0 110.254 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.55 -100.18 0.17 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.604 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.9 Cg_endo -53.94 -22.26 23.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.574 2.182 . . . . 0.0 112.548 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.607 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 3.0 mp 85.77 34.45 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 37.9 Cg_endo -65.35 -25.98 56.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.592 2.195 . . . . 0.0 112.737 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.1 t0 77.51 113.55 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.036 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.8 p90 15.97 57.64 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' CG ' ' HB2' ' A' ' 20' ' ' PRO . 10.5 mm-40 -74.44 69.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.365 . . . . 0.0 110.797 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mt -66.4 -66.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.13 32.01 20.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.737 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.404 ' O ' ' CA ' ' A' ' 10' ' ' GLY . . . 133.64 95.12 0.54 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.404 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.91 -7.75 5.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' 2TL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -77.88 -20.76 72.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.151 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.8 mt -55.2 -26.43 39.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.858 0.361 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . -84.5 -26.58 38.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.953 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 pp -93.8 1.42 56.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -107.33 -77.34 0.6 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.678 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' N ' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 C--N 1.331 0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.764 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.814 0.34 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.72 57.45 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.56 -60.96 3.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.648 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.5 m 45.6 29.32 0.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.331 . . . . 0.0 111.447 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.7 -17.5 35.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.3 p -61.49 -16.41 47.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -154.48 43.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.651 0.262 . . . . 0.0 111.044 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -30.79 11.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.159 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 6.3 mm -75.55 91.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.13 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.82 -38.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.892 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.19 44.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 111.241 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.21 95.11 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.325 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.448 ' HA ' ' HG3' ' A' ' 23' ' ' GLU . 1.7 m -66.18 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.365 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 41.9 mt 76.47 6.04 3.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.553 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 7.2 p -66.31 -5.67 3.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.815 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -98.14 27.21 4.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.249 0.547 . . . . 0.0 109.998 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -165.43 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.178 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.5 Cg_endo -52.69 -32.11 53.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.6 2.2 . . . . 0.0 111.861 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 2.7 mt 86.17 33.68 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 67.7 Cg_endo -72.51 -20.77 23.27 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.043 1.829 . . . . 0.0 112.316 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.3 t0 76.39 105.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.878 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 21' ' ' ASP . 1.3 p90 29.3 53.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.36 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HG3' ' HA ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -56.84 112.67 1.38 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 111.28 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.26 -76.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 53.07 32.88 13.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.572 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.22 95.35 1.4 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.699 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.02 -8.14 35.06 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -68.56 -30.55 73.06 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.156 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.9 mt -54.59 -23.38 16.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 0.0 111.314 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.96 -18.67 53.69 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.95 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.0 mt -93.68 25.52 3.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.359 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -130.17 -76.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.57 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -72.86 -8.95 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.95 -48.04 43.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.674 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.7 m -76.59 49.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.19 -22.58 26.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.766 0.317 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.447 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.9 t -65.81 -9.62 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.76 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.447 ' SG ' HG23 ' A' ' 6' ' ' THR . 0.8 OUTLIER -154.78 46.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.993 0.425 . . . . 0.0 110.76 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.7 m -57.8 -20.8 38.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 10' ' ' GLY . 1.1 mp -44.57 -71.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.242 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.577 ' N ' HG22 ' A' ' 9' ' ' ILE . . . 131.41 153.52 7.55 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.872 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.69 ' HA ' HG23 ' A' ' 24' ' ' ILE . . . -81.03 115.54 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 111.053 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.24 89.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' HA ' ' N ' ' A' ' 23' ' ' GLU . 1.7 m -66.9 -37.22 83.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.449 ' HB2' ' HG3' ' A' ' 20' ' ' PRO . 17.8 mt 76.38 1.43 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.994 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 15' ' ' VAL . 10.4 p -66.67 -2.01 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.06 21.17 10.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.107 0.479 . . . . 0.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -157.86 -92.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.2 Cg_endo -54.73 -28.66 58.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.574 2.183 . . . . 0.0 112.024 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 19' ' ' ILE . 39.9 mm 85.98 32.12 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 48.7 Cg_endo -68.77 -19.89 40.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.141 1.894 . . . . 0.0 112.61 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.2 t0 77.52 119.02 0.05 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 21' ' ' ASP . 5.4 p90 15.52 56.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 20' ' ' PRO . 52.4 mm-40 -89.21 68.98 8.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.989 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.69 HG23 ' HA ' ' A' ' 11' ' ' ALA . 3.6 mt -88.25 -51.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.85 28.58 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.23 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.57 78.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.691 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.586 0.232 . . . . 0.0 111.62 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.416 ' HA3' ' HA2' ' A' ' 10' ' ' GLY . . . . . . . . 0 CA--C 1.518 0.23 0 N-CA-C 113.372 0.109 . . . . 0.0 113.372 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 21.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.902 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.4 mt -64.72 -17.7 64.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.707 0.289 . . . . 0.0 111.186 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -107.6 -28.77 9.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.79 0.328 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.442 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.873 0.368 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -82.7 -81.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.25 34.12 4.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.573 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.7 m -74.58 -5.75 44.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.543 0.211 . . . . 0.0 111.567 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.64 -2.51 36.3 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -4.01 42.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 111.459 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.668 ' HG ' ' N ' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -155.02 65.92 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.93 0.395 . . . . 0.0 110.262 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -50.26 -27.03 5.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -59.82 102.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.72 163.24 50.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.788 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.98 111.58 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.96 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.83 88.15 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -66.44 -23.04 66.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.336 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 ' CG ' ' A' ' 18' ' ' PRO . 4.5 mt 67.07 1.83 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.685 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 15' ' ' VAL . 10.2 p -66.22 -6.88 4.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.839 0.352 . . . . 0.0 110.98 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.86 29.28 3.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.313 0.578 . . . . 0.0 110.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.57 -93.98 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.501 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CG ' HD22 ' A' ' 14' ' ' LEU . 9.2 Cg_endo -53.99 -31.63 64.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.629 2.22 . . . . 0.0 111.975 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 19' ' ' ILE . 27.3 mm 86.01 35.02 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 74.3 Cg_endo -73.24 -22.49 18.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.169 1.912 . . . . 0.0 112.15 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t0 78.61 109.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.036 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 32.2 55.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.467 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -88.12 51.31 2.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 111.241 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.83 -66.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.1 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.27 44.11 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.67 91.52 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.567 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.551 0.215 . . . . 0.0 111.327 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' ' HG ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.593 -0.203 . . . . 0.0 112.593 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.812 0.339 . . . . 0.0 111.231 179.884 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 120.434 -0.092 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -80.79 1.0 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.503 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.8 t90 -112.99 34.05 4.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.871 0.367 . . . . 0.0 110.807 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.512 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.833 0.349 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -82.49 86.66 6.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.11 72.41 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.0 m -156.97 26.29 0.32 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.709 0.29 . . . . 0.0 110.7 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.4 13.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 p -78.23 41.93 0.39 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 6' ' ' THR . 23.6 p 174.83 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.883 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 t -50.63 -25.8 4.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.868 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.554 HG21 ' O ' ' A' ' 24' ' ' ILE . 8.6 mm -52.25 104.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.807 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.94 174.41 0.04 OUTLIER Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.936 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.57 113.82 12.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 111.222 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.01 80.08 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -73.71 -24.97 59.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.602 HD13 ' OE2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER 67.6 2.42 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.297 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.9 p -66.25 -3.93 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 110.981 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.12 25.46 6.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.144 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.48 -102.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.424 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.629 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.6 Cg_endo -53.4 -25.62 32.25 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.47 2.114 . . . . 0.0 112.102 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.7 mp 86.05 37.71 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 53.8 Cg_endo -69.09 -22.69 34.79 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.28 1.987 . . . . 0.0 112.222 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 t0 76.13 109.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.995 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.5 p90 31.24 58.0 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.602 ' OE2' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -93.64 41.08 1.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.945 0.402 . . . . 0.0 111.665 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.554 ' O ' HG21 ' A' ' 9' ' ' ILE . 3.4 mt -58.76 -33.23 48.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.999 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.85 25.16 13.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.43 63.47 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.366 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 110.844 179.794 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.709 -0.156 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD12 ' HE3' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -63.4 -30.25 71.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 110.982 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.613 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.01 75.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 121.106 0.479 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.64 54.0 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.84 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.68 -51.07 2.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 m 42.16 31.82 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.9 -4.52 59.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.822 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.4 p -72.95 -5.08 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.252 . . . . 0.0 111.455 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -154.89 65.83 0.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.043 0.449 . . . . 0.0 110.107 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -50.18 -25.86 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.635 HG22 ' N ' ' A' ' 10' ' ' GLY . 1.4 mp -54.97 -66.58 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.346 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' ILE . . . 50.21 -140.9 17.4 Favored Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.358 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 106.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.912 0.387 . . . . 0.0 111.567 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.13 28.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' HB2' HG13 ' A' ' 24' ' ' ILE . 11.2 t -79.62 -29.58 41.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.83 0.348 . . . . 0.0 110.637 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' CB ' ' CG ' ' A' ' 20' ' ' PRO . 8.0 mt 69.93 3.1 4.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.613 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 15' ' ' VAL . 7.4 p -66.34 -7.24 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.965 0.412 . . . . 0.0 110.396 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.17 31.66 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.56 -94.9 0.1 OUTLIER Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.088 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.524 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 38.4 Cg_endo -67.29 -38.06 16.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.68 2.254 . . . . 0.0 112.462 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 19' ' ' ILE . 29.7 mm 86.21 59.82 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.439 ' CG ' ' CB ' ' A' ' 14' ' ' LEU . 64.2 Cg_endo -95.12 28.22 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.112 2.542 . . . . 0.0 111.715 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 23' ' ' GLU . 6.8 t70 63.27 117.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.847 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.449 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 9.3 p90 -24.78 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.659 0.599 . . . . 0.0 112.12 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -88.89 55.13 3.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.777 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.0 mt -88.89 -70.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 24' ' ' ILE . . . 67.67 41.15 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.413 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 24' ' ' ILE . . . 148.62 76.8 0.02 OUTLIER Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.357 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.246 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.786 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.645 0.26 . . . . 0.0 111.169 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 112.906 -0.077 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.91 4.25 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -131.85 34.97 3.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.437 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.696 179.662 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.85 0.357 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -83.15 41.51 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.288 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.07 -46.3 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.78 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m 45.75 26.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.192 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.12 -6.53 58.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.692 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 p -77.46 0.13 23.85 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -155.27 49.78 0.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.068 0.461 . . . . 0.0 110.801 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t -51.01 -22.5 2.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.347 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -44.76 -30.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.418 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.47 176.02 23.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.584 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -80.96 124.51 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 111.248 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.73 57.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.485 ' SG ' ' HB ' ' A' ' 15' ' ' VAL . 7.0 t -71.23 -30.1 65.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.693 HD13 ' OE2' ' A' ' 23' ' ' GLU . 6.2 mp 70.05 2.7 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.705 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.557 ' O ' HD13 ' A' ' 19' ' ' ILE . 7.3 p -66.28 -6.32 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.042 0.449 . . . . 0.0 110.282 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 30.32 2.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -161.31 -96.11 0.11 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.908 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 63.4 Cg_endo -73.35 -28.51 12.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.583 2.189 . . . . 0.0 112.357 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 19' ' ' ILE . 28.8 mm 86.03 58.83 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.44 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 21' ' ' ASP . 72.7 Cg_endo -94.19 38.82 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.914 2.409 . . . . 0.0 112.189 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 48.32 109.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.373 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -14.67 83.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.423 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.693 ' OE2' HD13 ' A' ' 14' ' ' LEU . 10.2 pt-20 -86.49 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.964 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.793 HG21 ' HB2' ' A' ' 27' ' ' ALA . 25.6 mm -75.83 -62.59 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 61.81 24.61 14.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.485 ' O ' HG22 ' A' ' 9' ' ' ILE . . . 142.46 74.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.816 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.793 ' HB2' HG21 ' A' ' 24' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.265 0 CA-C-O 120.472 -0.071 . . . . 0.0 113.185 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 11' ' ' ALA . 74.9 mt . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.298 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.331 0 CA-C-O 120.356 -0.135 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.2 mt -93.59 13.39 22.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.818 0.309 . . . . 0.0 111.769 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -131.09 -76.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.309 . . . . 0.0 111.141 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.546 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.411 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . 6.5 p-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.803 0.335 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -62.87 -17.8 62.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.3 -26.59 6.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.759 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.2 m -75.59 -1.25 23.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.95 -51.8 17.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 111.165 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -78.21 49.7 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.62 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.819 ' HG ' ' N ' ' A' ' 29' ' ' GLY . 23.6 p -178.26 44.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.597 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -50.9 -25.91 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 10' ' ' GLY . 4.1 mm -58.37 -74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.656 ' N ' HG22 ' A' ' 9' ' ' ILE . . . 79.99 -142.69 24.57 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.867 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.63 107.33 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 111.447 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.97 79.28 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 4.7 m -66.68 -31.1 71.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.187 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 20' ' ' PRO . 2.4 mt 69.78 5.12 5.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.65 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 11.0 p -66.25 -2.25 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -98.08 22.59 9.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.13 -104.7 0.36 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.637 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.9 Cg_endo -55.32 -21.87 30.97 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.172 1.914 . . . . 0.0 111.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.9 mp 86.21 43.0 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 15' ' ' VAL . 18.3 Cg_endo -56.36 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.877 1.718 . . . . 0.0 111.221 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 20' ' ' PRO . 1.4 p30 154.52 82.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.859 0.464 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 47.53 44.62 17.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.888 0.375 . . . . 0.0 110.334 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -65.08 115.1 5.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 111.805 -178.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.787 ' CG2' ' HB2' ' A' ' 27' ' ' ALA . 5.0 mt -89.05 -77.7 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.815 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 43.0 30.21 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.798 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 157.11 46.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.725 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.787 ' HB2' ' CG2' ' A' ' 24' ' ' ILE . . . . . . . . 0 C--N 1.331 -0.236 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.819 ' N ' ' HG ' ' A' ' 7' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 113.56 0.184 . . . . 0.0 113.56 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.774 0.287 . . . . 0.0 111.078 -179.858 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.375 0 N-CA-C 113.405 0.122 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 10.98 19.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.99 82.88 1.98 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 110.379 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.489 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.462 ' HB3' ' N ' ' A' ' 35' ' ' GLY . 12.0 p-10 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.898 0.38 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 60.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.21 8.21 42.56 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.675 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 37.73 -161.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.689 0.396 . . . . 0.0 111.872 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.84 -176.09 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.221 0.534 . . . . 0.0 112.119 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.0 p -78.58 58.82 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.261 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -153.52 34.65 0.45 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.286 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.48 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 14.3 m -50.27 -27.45 6.09 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.169 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 9' ' ' ILE . 6.4 mm -61.21 -20.58 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.988 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' GLY . . . -47.31 -68.68 1.09 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.312 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.26 64.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 111.323 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.438 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -170.59 75.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 1.7 m -70.9 -36.01 72.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 6.9 mp 73.82 3.59 4.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.108 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 15' ' ' VAL . 9.9 p -66.02 -2.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.269 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.56 23.3 7.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.205 0.526 . . . . 0.0 110.254 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.55 -100.18 0.17 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.604 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.619 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.9 Cg_endo -53.94 -22.26 23.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.574 2.182 . . . . 0.0 112.548 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.755 HG22 ' O ' ' A' ' 19' ' ' ILE . 3.0 mp 85.77 34.45 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 37.9 Cg_endo -65.35 -25.98 56.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.592 2.195 . . . . 0.0 112.737 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.1 t0 77.51 113.55 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.036 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.8 p90 15.97 57.64 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 20' ' ' PRO . 10.5 mm-40 -74.44 69.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.365 . . . . 0.0 110.797 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mt -66.4 -66.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.13 32.01 20.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.737 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.404 ' O ' ' CA ' ' A' ' 10' ' ' GLY . . . 133.64 95.12 0.54 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.404 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 120.454 -0.081 . . . . 0.0 113.151 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.404 HD22 HD21 ' A' ' 33' ' ' LEU . 60.8 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.858 0.361 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . . . . . . 0 N--CA 1.449 -0.454 0 N-CA-C 112.953 -0.059 . . . . 0.0 112.953 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.796 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.2 pp -93.8 1.42 56.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -107.33 -77.34 0.6 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.678 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' N ' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 C--N 1.331 0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.764 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.814 0.34 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.72 57.45 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.56 -60.96 3.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.648 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.5 m 45.6 29.32 0.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.331 . . . . 0.0 111.447 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.7 -17.5 35.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.3 p -61.49 -16.41 47.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -154.48 43.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.651 0.262 . . . . 0.0 111.044 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -30.79 11.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.159 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 9' ' ' ILE . 6.3 mm -75.55 91.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.13 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.82 -38.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.892 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 33' ' ' LEU . . . -81.19 44.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 111.241 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -173.21 95.11 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.325 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' HA ' ' HG3' ' A' ' 23' ' ' GLU . 1.7 m -66.18 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.365 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 20' ' ' PRO . 41.9 mt 76.47 6.04 3.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.576 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 7.2 p -66.31 -5.67 3.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.815 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -98.14 27.21 4.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.249 0.547 . . . . 0.0 109.998 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -165.43 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.178 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.5 Cg_endo -52.69 -32.11 53.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.6 2.2 . . . . 0.0 111.861 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.7 mt 86.17 33.68 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 67.7 Cg_endo -72.51 -20.77 23.27 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.043 1.829 . . . . 0.0 112.316 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 1.3 t0 76.39 105.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.878 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 21' ' ' ASP . 1.3 p90 29.3 53.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.36 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -56.84 112.67 1.38 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 111.28 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 26' ' ' GLY . 4.0 mp -89.26 -76.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 53.07 32.88 13.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.572 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 121.22 95.35 1.4 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.699 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.163 0 CA-C-O 120.526 -0.041 . . . . 0.0 113.156 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.9 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 0.0 111.314 -179.803 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.24 0 CA-C-O 120.42 -0.1 . . . . 0.0 112.95 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 11' ' ' ALA . 27.0 mt -93.68 25.52 3.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.359 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -130.17 -76.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.57 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -72.86 -8.95 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.95 -48.04 43.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.674 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.7 m -76.59 49.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.19 -22.58 26.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.766 0.317 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.447 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.9 t -65.81 -9.62 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.76 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' SG ' HG23 ' A' ' 6' ' ' THR . 0.8 OUTLIER -154.78 46.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.993 0.425 . . . . 0.0 110.76 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.7 m -57.8 -20.8 38.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 10' ' ' GLY . 1.1 mp -44.57 -71.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.242 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.577 ' N ' HG22 ' A' ' 9' ' ' ILE . . . 131.41 153.52 7.55 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.872 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.69 ' HA ' HG23 ' A' ' 24' ' ' ILE . . . -81.03 115.54 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 111.053 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.24 89.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' HA ' ' N ' ' A' ' 23' ' ' GLU . 1.7 m -66.9 -37.22 83.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.449 ' HB2' ' HG3' ' A' ' 20' ' ' PRO . 17.8 mt 76.38 1.43 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.994 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 15' ' ' VAL . 10.4 p -66.67 -2.01 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.06 21.17 10.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.107 0.479 . . . . 0.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -157.86 -92.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.2 Cg_endo -54.73 -28.66 58.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.574 2.183 . . . . 0.0 112.024 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 19' ' ' ILE . 39.9 mm 85.98 32.12 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 48.7 Cg_endo -68.77 -19.89 40.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.141 1.894 . . . . 0.0 112.61 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.2 t0 77.52 119.02 0.05 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 21' ' ' ASP . 5.4 p90 15.52 56.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 20' ' ' PRO . 52.4 mm-40 -89.21 68.98 8.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.989 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.69 HG23 ' HA ' ' A' ' 11' ' ' ALA . 3.6 mt -88.25 -51.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.85 28.58 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.23 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.57 78.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.691 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -72.67 -6.63 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.586 0.232 . . . . 0.0 111.62 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' 2TL . . . . . 0.664 HG22 ' O ' ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' HA3' ' HA2' ' A' ' 10' ' ' GLY . . . -42.6 -30.28 0.87 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.372 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 21.2 mt -60.34 -33.45 72.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.902 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.96 -26.61 15.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.381 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.4 mt -64.72 -17.7 64.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.707 0.289 . . . . 0.0 111.186 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -107.6 -28.77 9.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.79 0.328 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.442 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.873 0.368 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -82.7 -81.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.25 34.12 4.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.573 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HA ' HG23 ' A' ' 28' ' ' 2TL . 26.7 m -74.58 -5.75 44.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.543 0.211 . . . . 0.0 111.567 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.64 -2.51 36.3 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -4.01 42.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 111.459 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.02 65.92 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.93 0.395 . . . . 0.0 110.262 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -50.26 -27.03 5.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -59.82 102.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.72 163.24 50.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.788 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.98 111.58 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.96 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.83 88.15 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -66.44 -23.04 66.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.336 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 ' CG ' ' A' ' 18' ' ' PRO . 4.5 mt 67.07 1.83 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.685 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 15' ' ' VAL . 10.2 p -66.22 -6.88 4.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.839 0.352 . . . . 0.0 110.98 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.86 29.28 3.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.313 0.578 . . . . 0.0 110.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.57 -93.98 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.501 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CG ' HD22 ' A' ' 14' ' ' LEU . 9.2 Cg_endo -53.99 -31.63 64.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.629 2.22 . . . . 0.0 111.975 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 19' ' ' ILE . 27.3 mm 86.01 35.02 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 74.3 Cg_endo -73.24 -22.49 18.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.169 1.912 . . . . 0.0 112.15 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t0 78.61 109.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.036 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 32.2 55.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.467 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -88.12 51.31 2.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 111.241 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.83 -66.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.1 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.27 44.11 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.67 91.52 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.567 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' O ' ' OG1' ' A' ' 28' ' ' 2TL . . . -70.03 -30.12 67.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.551 0.215 . . . . 0.0 111.327 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' 2TL . . . . . 0.453 HG22 ' N ' ' A' ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' N ' HG22 ' A' ' 28' ' ' 2TL . . . 79.05 -52.28 3.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.593 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.6 mt -47.46 -27.98 1.97 Allowed 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.812 0.339 . . . . 0.0 111.231 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' DPN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 34' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.72 96.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.285 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -80.79 1.0 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.503 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.8 t90 -112.99 34.05 4.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.871 0.367 . . . . 0.0 110.807 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.512 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.833 0.349 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -82.49 86.66 6.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.11 72.41 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.755 ' HA ' HG23 ' A' ' 28' ' ' 2TL . 58.0 m -156.97 26.29 0.32 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.709 0.29 . . . . 0.0 110.7 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.4 13.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 p -78.23 41.93 0.39 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.445 ' O ' ' C ' ' A' ' 28' ' ' 2TL . 23.6 p 174.83 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.883 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 t -50.63 -25.8 4.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.868 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.554 HG21 ' O ' ' A' ' 24' ' ' ILE . 8.6 mm -52.25 104.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.807 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.94 174.41 0.04 OUTLIER Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.936 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.57 113.82 12.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 111.222 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.01 80.08 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -73.71 -24.97 59.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.602 HD13 ' OE2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER 67.6 2.42 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.297 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.9 p -66.25 -3.93 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 110.981 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.12 25.46 6.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.144 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.48 -102.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.424 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.629 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.6 Cg_endo -53.4 -25.62 32.25 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.47 2.114 . . . . 0.0 112.102 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.7 mp 86.05 37.71 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 53.8 Cg_endo -69.09 -22.69 34.79 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.28 1.987 . . . . 0.0 112.222 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 t0 76.13 109.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.995 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.5 p90 31.24 58.0 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.602 ' OE2' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -93.64 41.08 1.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.945 0.402 . . . . 0.0 111.665 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.554 ' O ' HG21 ' A' ' 9' ' ' ILE . 3.4 mt -58.76 -33.23 48.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.999 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.85 25.16 13.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.43 63.47 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.366 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 28' ' ' 2TL . . . -72.66 65.6 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 110.844 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' 2TL . . . . . 0.755 HG23 ' HA ' ' A' ' 4' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.88 -19.79 52.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.313 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt -72.46 -30.16 64.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.36 -55.94 7.28 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.709 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD12 ' HE3' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -63.4 -30.25 71.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 110.982 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.613 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.01 75.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 121.106 0.479 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.64 54.0 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.84 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.68 -51.07 2.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' SG ' HG22 ' A' ' 28' ' ' 2TL . 1.4 m 42.16 31.82 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.9 -4.52 59.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.822 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.4 p -72.95 -5.08 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.252 . . . . 0.0 111.455 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -154.89 65.83 0.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.043 0.449 . . . . 0.0 110.107 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -50.18 -25.86 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.635 HG22 ' N ' ' A' ' 10' ' ' GLY . 1.4 mp -54.97 -66.58 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.346 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' ILE . . . 50.21 -140.9 17.4 Favored Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.358 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 106.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.912 0.387 . . . . 0.0 111.567 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.13 28.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' HB2' HG13 ' A' ' 24' ' ' ILE . 11.2 t -79.62 -29.58 41.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.83 0.348 . . . . 0.0 110.637 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' CB ' ' CG ' ' A' ' 20' ' ' PRO . 8.0 mt 69.93 3.1 4.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.613 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 15' ' ' VAL . 7.4 p -66.34 -7.24 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.965 0.412 . . . . 0.0 110.396 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.17 31.66 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.56 -94.9 0.1 OUTLIER Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.088 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.524 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 38.4 Cg_endo -67.29 -38.06 16.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.68 2.254 . . . . 0.0 112.462 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 19' ' ' ILE . 29.7 mm 86.21 59.82 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.439 ' CG ' ' CB ' ' A' ' 14' ' ' LEU . 64.2 Cg_endo -95.12 28.22 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.112 2.542 . . . . 0.0 111.715 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 23' ' ' GLU . 6.8 t70 63.27 117.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.847 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.449 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 9.3 p90 -24.78 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.659 0.599 . . . . 0.0 112.12 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -88.89 55.13 3.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.777 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.0 mt -88.89 -70.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 24' ' ' ILE . . . 67.67 41.15 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.413 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 24' ' ' ILE . . . 148.62 76.8 0.02 OUTLIER Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.357 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 28' ' ' 2TL . . . -72.79 -3.6 26.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' 2TL . . . . . 0.66 HG22 ' O ' ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -57.63 -30.74 62.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.718 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.7 mt -57.14 -22.02 36.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.645 0.26 . . . . 0.0 111.169 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' DPN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 34' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.35 -40.29 98.76 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.906 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.91 4.25 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 31' ' ' DPN . 9.6 t-105 -131.85 34.97 3.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.437 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.696 179.662 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.85 0.357 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -83.15 41.51 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.288 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.07 -46.3 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.78 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.716 ' SG ' HG22 ' A' ' 28' ' ' 2TL . 1.7 m 45.75 26.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.192 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.12 -6.53 58.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.692 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 p -77.46 0.13 23.85 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -155.27 49.78 0.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.068 0.461 . . . . 0.0 110.801 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t -51.01 -22.5 2.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.347 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -44.76 -30.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.418 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.47 176.02 23.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.584 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -80.96 124.51 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 111.248 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.73 57.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.485 ' SG ' ' HB ' ' A' ' 15' ' ' VAL . 7.0 t -71.23 -30.1 65.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.693 HD13 ' OE2' ' A' ' 23' ' ' GLU . 6.2 mp 70.05 2.7 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.705 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.557 ' O ' HD13 ' A' ' 19' ' ' ILE . 7.3 p -66.28 -6.32 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.042 0.449 . . . . 0.0 110.282 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 30.32 2.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -161.31 -96.11 0.11 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.908 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 63.4 Cg_endo -73.35 -28.51 12.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.583 2.189 . . . . 0.0 112.357 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 19' ' ' ILE . 28.8 mm 86.03 58.83 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.44 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 21' ' ' ASP . 72.7 Cg_endo -94.19 38.82 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.914 2.409 . . . . 0.0 112.189 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 48.32 109.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.373 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -14.67 83.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.423 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.693 ' OE2' HD13 ' A' ' 14' ' ' LEU . 10.2 pt-20 -86.49 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.964 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.793 HG21 ' HB2' ' A' ' 27' ' ' ALA . 25.6 mm -75.83 -62.59 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 61.81 24.61 14.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.485 ' O ' HG22 ' A' ' 9' ' ' ILE . . . 142.46 74.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.816 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.793 ' HB2' HG21 ' A' ' 24' ' ' ILE . . . -72.95 0.51 11.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' 2TL . . . . . 0.716 HG22 ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -46.43 -33.03 5.69 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.185 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 11' ' ' ALA . 74.9 mt -61.23 -18.28 57.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.298 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.57 -11.13 68.17 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.081 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.2 mt -93.59 13.39 22.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.818 0.309 . . . . 0.0 111.769 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -131.09 -76.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.309 . . . . 0.0 111.141 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.546 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.411 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . 6.5 p-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.803 0.335 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -62.87 -17.8 62.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.3 -26.59 6.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.759 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HA ' ' OG1' ' A' ' 28' ' ' 2TL . 33.2 m -75.59 -1.25 23.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.95 -51.8 17.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 111.165 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -78.21 49.7 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.62 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 29' ' ' GLY . 23.6 p -178.26 44.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.597 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -50.9 -25.91 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 10' ' ' GLY . 4.1 mm -58.37 -74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.656 ' N ' HG22 ' A' ' 9' ' ' ILE . . . 79.99 -142.69 24.57 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.867 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.63 107.33 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 111.447 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.97 79.28 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 4.7 m -66.68 -31.1 71.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.187 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 20' ' ' PRO . 2.4 mt 69.78 5.12 5.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.65 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 11.0 p -66.25 -2.25 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -98.08 22.59 9.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.13 -104.7 0.36 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.637 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.9 Cg_endo -55.32 -21.87 30.97 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.172 1.914 . . . . 0.0 111.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.9 mp 86.21 43.0 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 15' ' ' VAL . 18.3 Cg_endo -56.36 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.877 1.718 . . . . 0.0 111.221 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 20' ' ' PRO . 1.4 p30 154.52 82.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.859 0.464 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 47.53 44.62 17.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.888 0.375 . . . . 0.0 110.334 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -65.08 115.1 5.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 111.805 -178.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.787 ' CG2' ' HB2' ' A' ' 27' ' ' ALA . 5.0 mt -89.05 -77.7 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.815 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 43.0 30.21 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.798 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 157.11 46.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.725 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.787 ' HB2' ' CG2' ' A' ' 24' ' ' ILE . . . -73.13 4.72 4.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' 2TL . . . . . 0.471 ' OG1' ' HA ' ' A' ' 4' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -43.05 -29.33 0.88 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.56 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -64.61 -31.57 72.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.774 0.287 . . . . 0.0 111.078 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' DPN . . . . . 0.401 ' HB3' ' CB ' ' A' ' 34' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.56 -39.79 16.03 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.405 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 10.98 19.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 31' ' ' DPN . 0.0 OUTLIER -134.99 82.88 1.98 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 110.379 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.489 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.462 ' HB3' ' N ' ' A' ' 35' ' ' GLY . 12.0 p-10 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.898 0.38 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 60.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.21 8.21 42.56 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.675 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 37.73 -161.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.689 0.396 . . . . 0.0 111.872 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 28' ' ' 2TL . . . -69.84 -176.09 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.221 0.534 . . . . 0.0 112.119 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.0 p -78.58 58.82 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.261 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -153.52 34.65 0.45 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.286 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.48 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 14.3 m -50.27 -27.45 6.09 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.169 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 9' ' ' ILE . 6.4 mm -61.21 -20.58 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.988 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' GLY . . . -47.31 -68.68 1.09 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.312 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.26 64.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 111.323 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.438 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -170.59 75.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 1.7 m -70.9 -36.01 72.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 6.9 mp 73.82 3.59 4.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.108 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 15' ' ' VAL . 9.9 p -66.02 -2.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.269 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.56 23.3 7.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.205 0.526 . . . . 0.0 110.254 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.55 -100.18 0.17 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.604 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.619 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.9 Cg_endo -53.94 -22.26 23.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.574 2.182 . . . . 0.0 112.548 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.755 HG22 ' O ' ' A' ' 19' ' ' ILE . 3.0 mp 85.77 34.45 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 37.9 Cg_endo -65.35 -25.98 56.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.592 2.195 . . . . 0.0 112.737 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.1 t0 77.51 113.55 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.036 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.8 p90 15.97 57.64 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 20' ' ' PRO . 10.5 mm-40 -74.44 69.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.365 . . . . 0.0 110.797 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mt -66.4 -66.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.13 32.01 20.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.737 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.404 ' O ' ' CA ' ' A' ' 10' ' ' GLY . . . 133.64 95.12 0.54 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.404 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.91 -7.75 5.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' 2TL . . . . . 0.592 ' O ' HG23 ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -77.88 -20.76 72.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.151 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.404 HD22 HD21 ' A' ' 33' ' ' LEU . 60.8 mt -55.2 -26.43 39.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.858 0.361 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . -84.5 -26.58 38.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.953 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.796 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.2 pp -93.8 1.42 56.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -107.33 -77.34 0.6 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.678 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' N ' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 C--N 1.331 0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.764 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.814 0.34 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.72 57.45 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.56 -60.96 3.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.648 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.5 m 45.6 29.32 0.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.331 . . . . 0.0 111.447 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.7 -17.5 35.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.3 p -61.49 -16.41 47.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -154.48 43.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.651 0.262 . . . . 0.0 111.044 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -30.79 11.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.159 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 9' ' ' ILE . 6.3 mm -75.55 91.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.13 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.82 -38.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.892 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 33' ' ' LEU . . . -81.19 44.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 111.241 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -173.21 95.11 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.325 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' HA ' ' HG3' ' A' ' 23' ' ' GLU . 1.7 m -66.18 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.365 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 20' ' ' PRO . 41.9 mt 76.47 6.04 3.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.576 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 7.2 p -66.31 -5.67 3.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.815 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -98.14 27.21 4.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.249 0.547 . . . . 0.0 109.998 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -165.43 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.178 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.5 Cg_endo -52.69 -32.11 53.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.6 2.2 . . . . 0.0 111.861 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.7 mt 86.17 33.68 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 67.7 Cg_endo -72.51 -20.77 23.27 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.043 1.829 . . . . 0.0 112.316 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 1.3 t0 76.39 105.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.878 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 21' ' ' ASP . 1.3 p90 29.3 53.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.36 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -56.84 112.67 1.38 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 111.28 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 26' ' ' GLY . 4.0 mp -89.26 -76.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 53.07 32.88 13.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.572 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 121.22 95.35 1.4 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.699 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.02 -8.14 35.06 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' 2TL . . . . . 0.565 ' O ' HG23 ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -68.56 -30.55 73.06 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.156 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.9 mt -54.59 -23.38 16.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 0.0 111.314 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' DPN . . . . . 0.473 ' CE1' HG21 ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.96 -18.67 53.69 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.95 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 11' ' ' ALA . 27.0 mt -93.68 25.52 3.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.359 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -130.17 -76.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.57 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -72.86 -8.95 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.95 -48.04 43.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.674 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.7 m -76.59 49.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.19 -22.58 26.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.766 0.317 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.447 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.9 t -65.81 -9.62 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.76 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.447 ' SG ' HG23 ' A' ' 6' ' ' THR . 0.8 OUTLIER -154.78 46.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.993 0.425 . . . . 0.0 110.76 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.7 m -57.8 -20.8 38.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 10' ' ' GLY . 1.1 mp -44.57 -71.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.242 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.577 ' N ' HG22 ' A' ' 9' ' ' ILE . . . 131.41 153.52 7.55 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.872 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.69 ' HA ' HG23 ' A' ' 24' ' ' ILE . . . -81.03 115.54 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 111.053 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.24 89.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' HA ' ' N ' ' A' ' 23' ' ' GLU . 1.7 m -66.9 -37.22 83.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.449 ' HB2' ' HG3' ' A' ' 20' ' ' PRO . 17.8 mt 76.38 1.43 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.994 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 15' ' ' VAL . 10.4 p -66.67 -2.01 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.06 21.17 10.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.107 0.479 . . . . 0.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -157.86 -92.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.2 Cg_endo -54.73 -28.66 58.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.574 2.183 . . . . 0.0 112.024 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 19' ' ' ILE . 39.9 mm 85.98 32.12 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 48.7 Cg_endo -68.77 -19.89 40.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.141 1.894 . . . . 0.0 112.61 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.2 t0 77.52 119.02 0.05 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 21' ' ' ASP . 5.4 p90 15.52 56.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 20' ' ' PRO . 52.4 mm-40 -89.21 68.98 8.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.989 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.69 HG23 ' HA ' ' A' ' 11' ' ' ALA . 3.6 mt -88.25 -51.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.85 28.58 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.23 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.57 78.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.691 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.586 0.232 . . . . 0.0 111.62 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.416 ' HA3' ' HA2' ' A' ' 10' ' ' GLY . . . . . . . . 0 CA--C 1.518 0.23 0 N-CA-C 113.372 0.109 . . . . 0.0 113.372 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 21.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.902 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.381 -0.288 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.4 mt -64.72 -17.7 64.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.707 0.289 . . . . 0.0 111.186 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -107.6 -28.77 9.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.79 0.328 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.442 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.873 0.368 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -82.7 -81.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.25 34.12 4.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.573 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.7 m -74.58 -5.75 44.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.543 0.211 . . . . 0.0 111.567 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.64 -2.51 36.3 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -4.01 42.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 111.459 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.668 ' HG ' ' N ' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -155.02 65.92 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.93 0.395 . . . . 0.0 110.262 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -50.26 -27.03 5.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -59.82 102.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.72 163.24 50.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.788 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.98 111.58 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.96 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.83 88.15 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -66.44 -23.04 66.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.336 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 ' CG ' ' A' ' 18' ' ' PRO . 4.5 mt 67.07 1.83 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.685 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 15' ' ' VAL . 10.2 p -66.22 -6.88 4.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.839 0.352 . . . . 0.0 110.98 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.86 29.28 3.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.313 0.578 . . . . 0.0 110.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.57 -93.98 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.501 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CG ' HD22 ' A' ' 14' ' ' LEU . 9.2 Cg_endo -53.99 -31.63 64.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.629 2.22 . . . . 0.0 111.975 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 19' ' ' ILE . 27.3 mm 86.01 35.02 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 74.3 Cg_endo -73.24 -22.49 18.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.169 1.912 . . . . 0.0 112.15 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t0 78.61 109.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.036 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 32.2 55.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.467 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -88.12 51.31 2.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 111.241 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.83 -66.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.1 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.27 44.11 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.67 91.52 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.567 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.551 0.215 . . . . 0.0 111.327 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' ' HG ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.593 -0.203 . . . . 0.0 112.593 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.812 0.339 . . . . 0.0 111.231 179.884 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 120.434 -0.092 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -80.79 1.0 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.503 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.8 t90 -112.99 34.05 4.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.871 0.367 . . . . 0.0 110.807 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.512 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.833 0.349 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -82.49 86.66 6.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.11 72.41 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.0 m -156.97 26.29 0.32 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.709 0.29 . . . . 0.0 110.7 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.4 13.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 p -78.23 41.93 0.39 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 6' ' ' THR . 23.6 p 174.83 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.883 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 t -50.63 -25.8 4.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.868 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.554 HG21 ' O ' ' A' ' 24' ' ' ILE . 8.6 mm -52.25 104.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.807 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.94 174.41 0.04 OUTLIER Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.936 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.57 113.82 12.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 111.222 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.01 80.08 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -73.71 -24.97 59.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.602 HD13 ' OE2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER 67.6 2.42 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.297 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.9 p -66.25 -3.93 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 110.981 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.12 25.46 6.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.144 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.48 -102.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.424 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.629 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.6 Cg_endo -53.4 -25.62 32.25 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.47 2.114 . . . . 0.0 112.102 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.7 mp 86.05 37.71 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 53.8 Cg_endo -69.09 -22.69 34.79 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.28 1.987 . . . . 0.0 112.222 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 t0 76.13 109.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.995 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.5 p90 31.24 58.0 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.602 ' OE2' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -93.64 41.08 1.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.945 0.402 . . . . 0.0 111.665 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.554 ' O ' HG21 ' A' ' 9' ' ' ILE . 3.4 mt -58.76 -33.23 48.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.999 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.85 25.16 13.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.43 63.47 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.366 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 110.844 179.794 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.709 -0.156 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD12 ' HE3' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -63.4 -30.25 71.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 110.982 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.613 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.01 75.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 1' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 121.106 0.479 . . . . 0.0 111.363 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.64 54.0 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.84 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.68 -51.07 2.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 m 42.16 31.82 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.9 -4.52 59.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.822 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.4 p -72.95 -5.08 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.252 . . . . 0.0 111.455 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -154.89 65.83 0.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.043 0.449 . . . . 0.0 110.107 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -50.18 -25.86 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.635 HG22 ' N ' ' A' ' 10' ' ' GLY . 1.4 mp -54.97 -66.58 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.346 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' ILE . . . 50.21 -140.9 17.4 Favored Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.358 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 106.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.912 0.387 . . . . 0.0 111.567 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.13 28.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' HB2' HG13 ' A' ' 24' ' ' ILE . 11.2 t -79.62 -29.58 41.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.83 0.348 . . . . 0.0 110.637 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' CB ' ' CG ' ' A' ' 20' ' ' PRO . 8.0 mt 69.93 3.1 4.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.613 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 15' ' ' VAL . 7.4 p -66.34 -7.24 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.965 0.412 . . . . 0.0 110.396 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.17 31.66 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.56 -94.9 0.1 OUTLIER Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.088 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.524 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 38.4 Cg_endo -67.29 -38.06 16.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.68 2.254 . . . . 0.0 112.462 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 19' ' ' ILE . 29.7 mm 86.21 59.82 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.439 ' CG ' ' CB ' ' A' ' 14' ' ' LEU . 64.2 Cg_endo -95.12 28.22 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.112 2.542 . . . . 0.0 111.715 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 23' ' ' GLU . 6.8 t70 63.27 117.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.847 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.449 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 9.3 p90 -24.78 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.659 0.599 . . . . 0.0 112.12 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -88.89 55.13 3.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.777 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.0 mt -88.89 -70.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 24' ' ' ILE . . . 67.67 41.15 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.413 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 24' ' ' ILE . . . 148.62 76.8 0.02 OUTLIER Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.357 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.246 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.786 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.645 0.26 . . . . 0.0 111.169 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 112.906 -0.077 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.91 4.25 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -131.85 34.97 3.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.437 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.696 179.662 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.85 0.357 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -83.15 41.51 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.288 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.07 -46.3 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.78 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 m 45.75 26.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.192 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.12 -6.53 58.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.692 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 p -77.46 0.13 23.85 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -155.27 49.78 0.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.068 0.461 . . . . 0.0 110.801 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t -51.01 -22.5 2.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.347 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -44.76 -30.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.418 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.47 176.02 23.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.584 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -80.96 124.51 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 111.248 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.73 57.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.485 ' SG ' ' HB ' ' A' ' 15' ' ' VAL . 7.0 t -71.23 -30.1 65.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.693 HD13 ' OE2' ' A' ' 23' ' ' GLU . 6.2 mp 70.05 2.7 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.705 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.557 ' O ' HD13 ' A' ' 19' ' ' ILE . 7.3 p -66.28 -6.32 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.042 0.449 . . . . 0.0 110.282 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 30.32 2.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -161.31 -96.11 0.11 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.908 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 63.4 Cg_endo -73.35 -28.51 12.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.583 2.189 . . . . 0.0 112.357 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 19' ' ' ILE . 28.8 mm 86.03 58.83 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.44 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 21' ' ' ASP . 72.7 Cg_endo -94.19 38.82 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.914 2.409 . . . . 0.0 112.189 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 48.32 109.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.373 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -14.67 83.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.423 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.693 ' OE2' HD13 ' A' ' 14' ' ' LEU . 10.2 pt-20 -86.49 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.964 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.793 HG21 ' HB2' ' A' ' 27' ' ' ALA . 25.6 mm -75.83 -62.59 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 61.81 24.61 14.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.485 ' O ' HG22 ' A' ' 9' ' ' ILE . . . 142.46 74.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.816 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.793 ' HB2' HG21 ' A' ' 24' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.265 0 CA-C-O 120.472 -0.071 . . . . 0.0 113.185 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 11' ' ' ALA . 74.9 mt . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.298 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.331 0 CA-C-O 120.356 -0.135 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.2 mt -93.59 13.39 22.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.818 0.309 . . . . 0.0 111.769 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -131.09 -76.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.309 . . . . 0.0 111.141 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.546 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.411 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.803 0.335 . . . . 0.0 110.97 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -62.87 -17.8 62.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.3 -26.59 6.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.759 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.2 m -75.59 -1.25 23.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.95 -51.8 17.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 111.165 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -78.21 49.7 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.62 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.819 ' HG ' ' N ' ' A' ' 29' ' ' GLY . 23.6 p -178.26 44.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.597 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -50.9 -25.91 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 10' ' ' GLY . 4.1 mm -58.37 -74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.656 ' N ' HG22 ' A' ' 9' ' ' ILE . . . 79.99 -142.69 24.57 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.867 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.63 107.33 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 111.447 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.97 79.28 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 4.7 m -66.68 -31.1 71.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.187 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 20' ' ' PRO . 2.4 mt 69.78 5.12 5.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.65 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 11.0 p -66.25 -2.25 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -98.08 22.59 9.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.13 -104.7 0.36 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.637 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.9 Cg_endo -55.32 -21.87 30.97 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.172 1.914 . . . . 0.0 111.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.9 mp 86.21 43.0 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 15' ' ' VAL . 18.3 Cg_endo -56.36 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.877 1.718 . . . . 0.0 111.221 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 20' ' ' PRO . 1.4 p30 154.52 82.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.859 0.464 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 47.53 44.62 17.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.888 0.375 . . . . 0.0 110.334 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -65.08 115.1 5.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 111.805 -178.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.787 ' CG2' ' HB2' ' A' ' 27' ' ' ALA . 5.0 mt -89.05 -77.7 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.815 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 43.0 30.21 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.798 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 157.11 46.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.725 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.787 ' HB2' ' CG2' ' A' ' 24' ' ' ILE . . . . . . . . 0 C--N 1.331 -0.236 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.819 ' N ' ' HG ' ' A' ' 7' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 113.56 0.184 . . . . 0.0 113.56 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.774 0.287 . . . . 0.0 111.078 -179.858 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.375 0 N-CA-C 113.405 0.122 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 10.98 19.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.99 82.88 1.98 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 110.379 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.489 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.462 ' HB3' ' N ' ' A' ' 35' ' ' GLY . 1.1 p30 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.898 0.38 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 60.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.21 8.21 42.56 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.675 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 37.73 -161.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.689 0.396 . . . . 0.0 111.872 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.84 -176.09 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.221 0.534 . . . . 0.0 112.119 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.0 p -78.58 58.82 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.261 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -153.52 34.65 0.45 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.286 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.48 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 14.3 m -50.27 -27.45 6.09 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.169 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 9' ' ' ILE . 6.4 mm -61.21 -20.58 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.988 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' GLY . . . -47.31 -68.68 1.09 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.312 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.26 64.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 111.323 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.438 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -170.59 75.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 1.7 m -70.9 -36.01 72.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 6.9 mp 73.82 3.59 4.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.108 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 15' ' ' VAL . 9.9 p -66.02 -2.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.269 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.56 23.3 7.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.205 0.526 . . . . 0.0 110.254 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.55 -100.18 0.17 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.604 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.619 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.9 Cg_endo -53.94 -22.26 23.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.574 2.182 . . . . 0.0 112.548 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.755 HG22 ' O ' ' A' ' 19' ' ' ILE . 3.0 mp 85.77 34.45 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 37.9 Cg_endo -65.35 -25.98 56.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.592 2.195 . . . . 0.0 112.737 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.1 t0 77.51 113.55 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.036 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.8 p90 15.97 57.64 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 20' ' ' PRO . 10.5 mm-40 -74.44 69.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.365 . . . . 0.0 110.797 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mt -66.4 -66.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.13 32.01 20.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.737 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.404 ' O ' ' CA ' ' A' ' 10' ' ' GLY . . . 133.64 95.12 0.54 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.404 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 120.454 -0.081 . . . . 0.0 113.151 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.404 HD22 HD21 ' A' ' 33' ' ' LEU . 60.8 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.858 0.361 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . . . . . . 0 N--CA 1.449 -0.454 0 N-CA-C 112.953 -0.059 . . . . 0.0 112.953 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.796 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.2 pp -93.8 1.42 56.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -107.33 -77.34 0.6 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.678 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' N ' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 C--N 1.331 0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.764 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.814 0.34 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.72 57.45 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.56 -60.96 3.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.648 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.5 m 45.6 29.32 0.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.331 . . . . 0.0 111.447 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.7 -17.5 35.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.3 p -61.49 -16.41 47.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -154.48 43.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.651 0.262 . . . . 0.0 111.044 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -30.79 11.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.159 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 9' ' ' ILE . 6.3 mm -75.55 91.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.13 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.82 -38.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.892 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 33' ' ' LEU . . . -81.19 44.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 111.241 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -173.21 95.11 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.325 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' HA ' ' HG3' ' A' ' 23' ' ' GLU . 1.7 m -66.18 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.365 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 20' ' ' PRO . 41.9 mt 76.47 6.04 3.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.576 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 7.2 p -66.31 -5.67 3.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.815 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -98.14 27.21 4.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.249 0.547 . . . . 0.0 109.998 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -165.43 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.178 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.5 Cg_endo -52.69 -32.11 53.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.6 2.2 . . . . 0.0 111.861 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.7 mt 86.17 33.68 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 67.7 Cg_endo -72.51 -20.77 23.27 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.043 1.829 . . . . 0.0 112.316 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 1.3 t0 76.39 105.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.878 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 21' ' ' ASP . 1.3 p90 29.3 53.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.36 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -56.84 112.67 1.38 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 111.28 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 26' ' ' GLY . 4.0 mp -89.26 -76.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 53.07 32.88 13.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.572 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 121.22 95.35 1.4 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.699 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.163 0 CA-C-O 120.526 -0.041 . . . . 0.0 113.156 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.9 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 0.0 111.314 -179.803 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.24 0 CA-C-O 120.42 -0.1 . . . . 0.0 112.95 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 11' ' ' ALA . 27.0 mt -93.68 25.52 3.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.359 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -130.17 -76.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.57 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -72.86 -8.95 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.95 -48.04 43.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.674 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.7 m -76.59 49.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.19 -22.58 26.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.766 0.317 . . . . 0.0 111.244 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.447 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.9 t -65.81 -9.62 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.76 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' SG ' HG23 ' A' ' 6' ' ' THR . 0.8 OUTLIER -154.78 46.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.993 0.425 . . . . 0.0 110.76 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.7 m -57.8 -20.8 38.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 10' ' ' GLY . 1.1 mp -44.57 -71.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.242 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.577 ' N ' HG22 ' A' ' 9' ' ' ILE . . . 131.41 153.52 7.55 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.872 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.69 ' HA ' HG23 ' A' ' 24' ' ' ILE . . . -81.03 115.54 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 111.053 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.24 89.87 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' HA ' ' N ' ' A' ' 23' ' ' GLU . 1.7 m -66.9 -37.22 83.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.449 ' HB2' ' HG3' ' A' ' 20' ' ' PRO . 17.8 mt 76.38 1.43 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.994 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 15' ' ' VAL . 10.4 p -66.67 -2.01 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.06 21.17 10.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.107 0.479 . . . . 0.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -157.86 -92.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.2 Cg_endo -54.73 -28.66 58.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.574 2.183 . . . . 0.0 112.024 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 19' ' ' ILE . 39.9 mm 85.98 32.12 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 48.7 Cg_endo -68.77 -19.89 40.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.141 1.894 . . . . 0.0 112.61 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.2 t0 77.52 119.02 0.05 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 21' ' ' ASP . 5.4 p90 15.52 56.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 20' ' ' PRO . 52.4 mm-40 -89.21 68.98 8.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.941 0.401 . . . . 0.0 110.989 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.69 HG23 ' HA ' ' A' ' 11' ' ' ALA . 3.6 mt -88.25 -51.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.85 28.58 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.23 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.57 78.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.691 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 30' ' ' LEU . . . -72.67 -6.63 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.586 0.232 . . . . 0.0 111.62 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' 2TL . . . . . 0.664 HG22 ' O ' ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' HA3' ' HA2' ' A' ' 10' ' ' GLY . . . -42.6 -30.28 0.87 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.372 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 27' ' ' ALA . 21.2 mt -60.34 -33.45 72.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.902 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.96 -26.61 15.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.381 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.4 mt -64.72 -17.7 64.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.707 0.289 . . . . 0.0 111.186 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -107.6 -28.77 9.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.79 0.328 . . . . 0.0 110.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.442 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.873 0.368 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -82.7 -81.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.25 34.12 4.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.573 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HA ' HG23 ' A' ' 28' ' ' 2TL . 26.7 m -74.58 -5.75 44.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.543 0.211 . . . . 0.0 111.567 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.64 -2.51 36.3 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 p -77.34 -4.01 42.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 111.459 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.02 65.92 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.93 0.395 . . . . 0.0 110.262 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -50.26 -27.03 5.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -59.82 102.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.72 163.24 50.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.788 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.98 111.58 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.96 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.83 88.15 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -66.44 -23.04 66.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.336 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 ' CG ' ' A' ' 18' ' ' PRO . 4.5 mt 67.07 1.83 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.685 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 15' ' ' VAL . 10.2 p -66.22 -6.88 4.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.839 0.352 . . . . 0.0 110.98 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.86 29.28 3.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.313 0.578 . . . . 0.0 110.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.57 -93.98 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.501 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CG ' HD22 ' A' ' 14' ' ' LEU . 9.2 Cg_endo -53.99 -31.63 64.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.629 2.22 . . . . 0.0 111.975 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 19' ' ' ILE . 27.3 mm 86.01 35.02 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 74.3 Cg_endo -73.24 -22.49 18.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.169 1.912 . . . . 0.0 112.15 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t0 78.61 109.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.036 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 32.2 55.29 0.34 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.467 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -88.12 51.31 2.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 111.241 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.83 -66.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.1 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.27 44.11 7.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.67 91.52 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.567 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' O ' ' OG1' ' A' ' 28' ' ' 2TL . . . -70.03 -30.12 67.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.551 0.215 . . . . 0.0 111.327 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' 2TL . . . . . 0.453 HG22 ' N ' ' A' ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' N ' HG22 ' A' ' 28' ' ' 2TL . . . 79.05 -52.28 3.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.593 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.6 mt -47.46 -27.98 1.97 Allowed 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.812 0.339 . . . . 0.0 111.231 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' DPN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 34' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.72 96.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.285 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -80.79 1.0 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.503 ' N ' HD12 ' A' ' 33' ' ' LEU . 1.8 t90 -112.99 34.05 4.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.871 0.367 . . . . 0.0 110.807 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.512 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.833 0.349 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -82.49 86.66 6.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.11 72.41 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.755 ' HA ' HG23 ' A' ' 28' ' ' 2TL . 58.0 m -156.97 26.29 0.32 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.709 0.29 . . . . 0.0 110.7 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.4 13.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 p -78.23 41.93 0.39 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.445 ' O ' ' C ' ' A' ' 28' ' ' 2TL . 23.6 p 174.83 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.883 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 t -50.63 -25.8 4.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.868 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.554 HG21 ' O ' ' A' ' 24' ' ' ILE . 8.6 mm -52.25 104.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.807 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.94 174.41 0.04 OUTLIER Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.936 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.57 113.82 12.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 111.222 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.01 80.08 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 1.2 m -73.71 -24.97 59.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.602 HD13 ' OE2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER 67.6 2.42 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.297 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.9 p -66.25 -3.93 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 110.981 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.12 25.46 6.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.144 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.48 -102.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.424 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.629 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.6 Cg_endo -53.4 -25.62 32.25 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.47 2.114 . . . . 0.0 112.102 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.7 mp 86.05 37.71 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 53.8 Cg_endo -69.09 -22.69 34.79 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.28 1.987 . . . . 0.0 112.222 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 t0 76.13 109.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.995 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.5 p90 31.24 58.0 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.602 ' OE2' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -93.64 41.08 1.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.945 0.402 . . . . 0.0 111.665 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.554 ' O ' HG21 ' A' ' 9' ' ' ILE . 3.4 mt -58.76 -33.23 48.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.999 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.85 25.16 13.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.43 63.47 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.366 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 28' ' ' 2TL . . . -72.66 65.6 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 110.844 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' 2TL . . . . . 0.755 HG23 ' HA ' ' A' ' 4' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.88 -19.79 52.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.313 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt -72.46 -30.16 64.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.36 -55.94 7.28 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.709 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD12 ' HE3' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -63.4 -30.25 71.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 110.982 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.613 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.01 75.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.505 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 1' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 121.106 0.479 . . . . 0.0 111.363 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.64 54.0 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.84 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.68 -51.07 2.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' SG ' HG22 ' A' ' 28' ' ' 2TL . 1.4 m 42.16 31.82 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.9 -4.52 59.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.822 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.4 p -72.95 -5.08 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.252 . . . . 0.0 111.455 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -154.89 65.83 0.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.043 0.449 . . . . 0.0 110.107 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -50.18 -25.86 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.635 HG22 ' N ' ' A' ' 10' ' ' GLY . 1.4 mp -54.97 -66.58 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.346 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' ILE . . . 50.21 -140.9 17.4 Favored Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.358 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.84 106.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.912 0.387 . . . . 0.0 111.567 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.13 28.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' HB2' HG13 ' A' ' 24' ' ' ILE . 11.2 t -79.62 -29.58 41.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.83 0.348 . . . . 0.0 110.637 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' CB ' ' CG ' ' A' ' 20' ' ' PRO . 8.0 mt 69.93 3.1 4.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.613 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 15' ' ' VAL . 7.4 p -66.34 -7.24 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.965 0.412 . . . . 0.0 110.396 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.17 31.66 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.56 -94.9 0.1 OUTLIER Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.088 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.524 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 38.4 Cg_endo -67.29 -38.06 16.34 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.68 2.254 . . . . 0.0 112.462 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 19' ' ' ILE . 29.7 mm 86.21 59.82 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.439 ' CG ' ' CB ' ' A' ' 14' ' ' LEU . 64.2 Cg_endo -95.12 28.22 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.112 2.542 . . . . 0.0 111.715 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 23' ' ' GLU . 6.8 t70 63.27 117.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.847 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.449 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 9.3 p90 -24.78 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.659 0.599 . . . . 0.0 112.12 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -88.89 55.13 3.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.777 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.0 mt -88.89 -70.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 24' ' ' ILE . . . 67.67 41.15 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.413 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 24' ' ' ILE . . . 148.62 76.8 0.02 OUTLIER Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.357 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 28' ' ' 2TL . . . -72.79 -3.6 26.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' 2TL . . . . . 0.66 HG22 ' O ' ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -57.63 -30.74 62.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.718 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.7 mt -57.14 -22.02 36.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.645 0.26 . . . . 0.0 111.169 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' DPN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 34' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.35 -40.29 98.76 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.906 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.91 4.25 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 31' ' ' DPN . 9.6 t-105 -131.85 34.97 3.81 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.437 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.696 179.662 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.85 0.357 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -83.15 41.51 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.288 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.07 -46.3 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.78 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.716 ' SG ' HG22 ' A' ' 28' ' ' 2TL . 1.7 m 45.75 26.7 0.38 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.192 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.12 -6.53 58.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.692 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 p -77.46 0.13 23.85 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -155.27 49.78 0.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.068 0.461 . . . . 0.0 110.801 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t -51.01 -22.5 2.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.347 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -44.76 -30.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.418 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.47 176.02 23.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.584 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -80.96 124.51 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 111.248 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.73 57.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.485 ' SG ' ' HB ' ' A' ' 15' ' ' VAL . 7.0 t -71.23 -30.1 65.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.693 HD13 ' OE2' ' A' ' 23' ' ' GLU . 6.2 mp 70.05 2.7 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.705 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.557 ' O ' HD13 ' A' ' 19' ' ' ILE . 7.3 p -66.28 -6.32 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.042 0.449 . . . . 0.0 110.282 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 30.32 2.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -161.31 -96.11 0.11 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.908 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 63.4 Cg_endo -73.35 -28.51 12.26 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.583 2.189 . . . . 0.0 112.357 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 19' ' ' ILE . 28.8 mm 86.03 58.83 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.44 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 21' ' ' ASP . 72.7 Cg_endo -94.19 38.82 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.914 2.409 . . . . 0.0 112.189 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 48.32 109.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.373 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -14.67 83.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.423 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.693 ' OE2' HD13 ' A' ' 14' ' ' LEU . 10.2 pt-20 -86.49 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.964 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.793 HG21 ' HB2' ' A' ' 27' ' ' ALA . 25.6 mm -75.83 -62.59 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 61.81 24.61 14.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.485 ' O ' HG22 ' A' ' 9' ' ' ILE . . . 142.46 74.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.816 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.793 ' HB2' HG21 ' A' ' 24' ' ' ILE . . . -72.95 0.51 11.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' 2TL . . . . . 0.716 HG22 ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -46.43 -33.03 5.69 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.185 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 11' ' ' ALA . 74.9 mt -61.23 -18.28 57.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 111.298 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.57 -11.13 68.17 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.081 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.2 mt -93.59 13.39 22.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.818 0.309 . . . . 0.0 111.769 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -131.09 -76.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.309 . . . . 0.0 111.141 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.546 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.411 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.803 0.335 . . . . 0.0 110.97 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -62.87 -17.8 62.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.3 -26.59 6.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.759 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HA ' ' OG1' ' A' ' 28' ' ' 2TL . 33.2 m -75.59 -1.25 23.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.95 -51.8 17.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 111.165 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -78.21 49.7 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.62 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 29' ' ' GLY . 23.6 p -178.26 44.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.597 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -50.9 -25.91 5.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 10' ' ' GLY . 4.1 mm -58.37 -74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.656 ' N ' HG22 ' A' ' 9' ' ' ILE . . . 79.99 -142.69 24.57 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.867 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.63 107.33 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 111.447 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.97 79.28 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 4.7 m -66.68 -31.1 71.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.187 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 20' ' ' PRO . 2.4 mt 69.78 5.12 5.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.65 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 11.0 p -66.25 -2.25 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -98.08 22.59 9.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.13 -104.7 0.36 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.637 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.9 Cg_endo -55.32 -21.87 30.97 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.172 1.914 . . . . 0.0 111.781 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.9 mp 86.21 43.0 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 15' ' ' VAL . 18.3 Cg_endo -56.36 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 121.877 1.718 . . . . 0.0 111.221 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 20' ' ' PRO . 1.4 p30 154.52 82.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.859 0.464 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 47.53 44.62 17.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.888 0.375 . . . . 0.0 110.334 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -65.08 115.1 5.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 111.805 -178.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.787 ' CG2' ' HB2' ' A' ' 27' ' ' ALA . 5.0 mt -89.05 -77.7 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.815 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 43.0 30.21 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.798 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.617 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 157.11 46.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.725 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.787 ' HB2' ' CG2' ' A' ' 24' ' ' ILE . . . -73.13 4.72 4.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' 2TL . . . . . 0.471 ' OG1' ' HA ' ' A' ' 4' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -43.05 -29.33 0.88 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.56 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -64.61 -31.57 72.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.774 0.287 . . . . 0.0 111.078 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' DPN . . . . . 0.401 ' HB3' ' CB ' ' A' ' 34' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.56 -39.79 16.03 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.405 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 10.98 19.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 31' ' ' DPN . 0.0 OUTLIER -134.99 82.88 1.98 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.303 . . . . 0.0 110.379 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.489 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.462 ' HB3' ' N ' ' A' ' 35' ' ' GLY . 1.1 p30 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.898 0.38 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 60.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.21 8.21 42.56 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.675 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 37.73 -161.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.689 0.396 . . . . 0.0 111.872 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 28' ' ' 2TL . . . -69.84 -176.09 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.221 0.534 . . . . 0.0 112.119 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.0 p -78.58 58.82 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.261 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.552 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -153.52 34.65 0.45 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.286 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.48 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 14.3 m -50.27 -27.45 6.09 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.169 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 9' ' ' ILE . 6.4 mm -61.21 -20.58 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.988 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 26' ' ' GLY . . . -47.31 -68.68 1.09 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.312 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.26 64.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 111.323 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.438 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -170.59 75.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 1.7 m -70.9 -36.01 72.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 6.9 mp 73.82 3.59 4.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.108 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 15' ' ' VAL . 9.9 p -66.02 -2.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.269 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.56 23.3 7.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.205 0.526 . . . . 0.0 110.254 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.55 -100.18 0.17 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.604 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.619 ' O ' HD12 ' A' ' 19' ' ' ILE . 9.9 Cg_endo -53.94 -22.26 23.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.574 2.182 . . . . 0.0 112.548 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.755 HG22 ' O ' ' A' ' 19' ' ' ILE . 3.0 mp 85.77 34.45 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 37.9 Cg_endo -65.35 -25.98 56.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.592 2.195 . . . . 0.0 112.737 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.1 t0 77.51 113.55 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.036 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.8 p90 15.97 57.64 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 20' ' ' PRO . 10.5 mm-40 -74.44 69.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.365 . . . . 0.0 110.797 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mt -66.4 -66.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.13 32.01 20.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.737 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.404 ' O ' ' CA ' ' A' ' 10' ' ' GLY . . . 133.64 95.12 0.54 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.404 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.91 -7.75 5.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' 2TL . . . . . 0.592 ' O ' HG23 ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -77.88 -20.76 72.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.151 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.404 HD22 HD21 ' A' ' 33' ' ' LEU . 60.8 mt -55.2 -26.43 39.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.858 0.361 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' DPN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . -84.5 -26.58 38.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.953 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.796 HD12 ' O ' ' A' ' 33' ' ' LEU . 1.2 pp -93.8 1.42 56.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -107.33 -77.34 0.6 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.678 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' N ' ' HB3' ' A' ' 1' ' ' ASN . . . . . . . . 0 C--N 1.331 0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.764 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.814 0.34 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.72 57.45 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.56 -60.96 3.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.648 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.5 m 45.6 29.32 0.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.331 . . . . 0.0 111.447 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.7 -17.5 35.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.3 p -61.49 -16.41 47.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.394 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -154.48 43.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.651 0.262 . . . . 0.0 111.044 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -30.79 11.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.159 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 9' ' ' ILE . 6.3 mm -75.55 91.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.13 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.82 -38.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.892 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 33' ' ' LEU . . . -81.19 44.62 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 111.241 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -173.21 95.11 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.325 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' HA ' ' HG3' ' A' ' 23' ' ' GLU . 1.7 m -66.18 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.365 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 20' ' ' PRO . 41.9 mt 76.47 6.04 3.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.957 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.576 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 7.2 p -66.31 -5.67 3.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.815 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -98.14 27.21 4.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.249 0.547 . . . . 0.0 109.998 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -165.43 -92.83 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.178 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 9.5 Cg_endo -52.69 -32.11 53.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.6 2.2 . . . . 0.0 111.861 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 19' ' ' ILE . 2.7 mt 86.17 33.68 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 19' ' ' ILE . 67.7 Cg_endo -72.51 -20.77 23.27 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.043 1.829 . . . . 0.0 112.316 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 1.3 t0 76.39 105.96 0.08 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.878 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 21' ' ' ASP . 1.3 p90 29.3 53.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.36 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -56.84 112.67 1.38 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.153 0.501 . . . . 0.0 111.28 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 26' ' ' GLY . 4.0 mp -89.26 -76.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 53.07 32.88 13.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.572 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 121.22 95.35 1.4 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.699 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.02 -8.14 35.06 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' 2TL . . . . . 0.565 ' O ' HG23 ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . -68.56 -30.55 73.06 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.156 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.9 mt -54.59 -23.38 16.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 0.0 111.314 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' DPN . . . . . 0.473 ' CE1' HG21 ' A' ' 28' ' ' 2TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.96 -18.67 53.69 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.95 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 11' ' ' ALA . 27.0 mt -93.68 25.52 3.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 111.359 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 34' ' ' TRP . 0.0 OUTLIER -130.17 -76.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.57 180.0 . . . . . . . . 0 0 . 1 stop_ save_